newsfilter
← Latest News
GlobeNewswire·

Morphic to Present at the Canaccord Genuity 43rd Annual Growth Conference

WALTHAM, Mass., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ:MORF), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today